CurrentBlue Cross Blue Shield - MassachusettsPolicy 745

Multimarker Nutritional / Nutrient Panel Testing

This policy governs coverage for multimarker nutritional or nutrient panel testing (e.g., NutrEval, SpectraCell micronutrient testing) for Blue Cross Blue Shield Massachusetts members and specifies inpatient/outpatient authorization rules and coverage stance.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyMultimarker Nutritional / Nutrient Panel Testing

Policy CodePolicy 745

Change TypeNo material changes

Effective DateJan 1, 2016

Next Review Date

Key ActionObtain precertification/preauthorization for inpatient services described in this policy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Investigationalcoverage stance

Inpatientprecert required

Not coveredoutpatient coverage

None listedcoding availability

Insufficientevidence

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

Investigational / Not covered with criteria

Coverage determination

Policy stance: Nutrient/nutritional panel testing is considered investigational for all indications including but not limited to testing for nutritional deficiencies in individuals with mood disorders, fibromyalgia, unexplained fatigue and healthy individuals.

No clinical evidence that panel testing improves net health outcome or is superior to individual nutrient testing.

For outpatient services, multimarker nutritional panel testing is not a covered service for the specified commercial and Medicare products. Specifically, outpatient testing is not a covered service for Commercial Managed Care (HMO and POS), Commercial PPO and Indemnity, Medicare HMO BlueSM, and Medicare PPO BlueSM members.

Nutrient/nutritional panel testing is considered investigational for all indications because available evidence is insufficient to show that these panels improve health outcomes or are superior to single-nutrient testing. Therefore, such testing is not medically necessary for evaluation of nutritional deficiencies in conditions including but not limited to mood disorders, fibromyalgia, unexplained fatigue, or for healthy individuals seeking optimization.

Covered Indications

Covered indications

Not covered for all indications: Testing is considered investigational for all indications, including testing proposed for chronic conditions (e.g., mood disorders, fibromyalgia, unexplained fatigue) and for healthy individuals seeking optimization.

There is no direct evidence that multimarker nutritional panel testing improves health outcomes or that it is superior to targeted testing of individual nutrients.

Provider Actions

Prior Authorization

Prior Authorization Required

For services described in this policy, precertification/preauthorization is required for all products when the procedure is performed as an inpatient service. Lack of required inpatient authorization may result in a denial of coverage or payment.

Precertification/Preauthorization required for ALL products when performed inpatient

Note

Provider Actions — Inpatient Precertification

Providers must obtain inpatient authorization before scheduling or performing inpatient procedures covered by this policy. Contact Blue Cross Blue Shield of Massachusetts precertification team or use the payer's designated portal to request authorization and retain documentation of the approval in the patient record.

Obtain authorization prior to inpatient admission or procedure
Retain authorization documentation in the medical record
Use payer portal or precertification phone line as directed

Documentation Required

Coding and Documentation Requirements

Providers should report all services using current industry-standard procedure, revenue, and diagnosis codes and include applicable modifiers. Accurate coding and documentation support authorization decisions and claims processing.

Use most up-to-date CPT/HCPCS and ICD-10 codes
Include applicable modifiers and revenue codes
Document clinical rationale and authorization references on claims and in the chart

Denial Risk

Coverage Denial Triggers

Nutrient/nutritional panel testing is designated as investigational for all indications and outpatient testing is not a covered service for commercial and Medicare products. Requests for investigational services or outpatient procedures inconsistent with this policy may be denied.

Investigational designation may trigger coverage denial
Outpatient nutrient/nutritional panel testing is not covered for Commercial and Medicare products

Denial Risk

Denial Risk — Authorization and Documentation

Failure to obtain required inpatient precertification or to submit accurate, up-to-date coding and supporting documentation may result in claim denial or delayed payment.

No inpatient authorization = potential denial of coverage/payment
Incomplete or outdated coding/documentation = potential claim denial or payment delay

Background

Multimarker nutritional panel tests (examples include Genova Diagnostics’ NutrEval FMV or NutrEval Plasma and the SpectraCell Micronutrient Test) analyze a broad array of analytes — vitamins, minerals, amino acids, fatty acids, antioxidants and related metabolites — and generate reports that categorize nutrient status and often provide supplementation recommendations. These panels are promoted for patients with chronic symptoms such as mood disorders, fibromyalgia, or unexplained fatigue and for healthy individuals seeking optimization. However, there is no direct evidence that panel testing improves clinical outcomes or is superior to targeted single‑nutrient testing.

Definitions

NutrEval FMV / NutrEval Plasma — Genova Diagnostics

Test namesNutrEval FMV (urine first-morning void) and NutrEval Plasma (plasma, fasting)

Analytes reported>100 markers including organic acids, amino acids, fatty acids, markers of oxidative stress (glutathione, CoQ10, oxidative injury/DNA damage) and nutrient elements

Result categorizationResults categorized as minimal, moderate, or high need for support

Report outputPatient report includes supplementation recommendations and dosages for items categorized as high need

Primary purposeIdentify presumed nutritional deficiencies and generate personalized supplement recommendations

SpectraCell Micronutrient Test

Test nameSpectraCell Micronutrient Test

ScopeAssess how well the body uses ~31 vitamins, minerals, amino and fatty acids, antioxidants, and metabolites

Result categoriesResults reported as adequate, borderline, or deficient

OutputProvides supplementation suggestions based on identified cellular functional deficiencies

Primary purposeDetect cellular-level functional nutrient deficiencies to guide supplement recommendations

Revision History

2026-02annual reviewLatest

Annual policy review; literature search updated through November 10, 2025; policy statement unchanged.

2025-01annual review

Annual policy review; references updated; policy statements unchanged.

2024-01annual review

Annual policy review; references updated; policy statements unchanged.

2023-02annual review

Annual policy review with minor editorial refinements to policy statements; intent unchanged.

2022-02annual review

Annual policy review; description, summary, and references updated; policy statements unchanged.

2021-02annual review

Annual policy review; description, summary, and references updated; policy statements unchanged.

2020-01annual review

Annual policy review; description, summary, and references updated; policy statements unchanged.

2019-02annual review

Annual policy review; description, summary, and references updated; policy statements unchanged.

2018-03annual review

Annual policy review; new references added.

2016-01-01policy effective

New medical policy describing investigational indications became effective.

OpenPayer

Multimarker Nutritional / Nutrient Panel Testing

Coverage Criteria

Covered Indications

Not Covered

Coding

Provider Actions

Ordering Requirements

Background

Definitions

Frequency Limits

Revision History